Skip to main content

Table 2 Protective effects of different doses of anti-LIF and doxorubicin on the survival rates of mice in each study group

From: The effect of the anti-leukemia inhibitory factor on the immune system in the Balb/c mice bearing breast cancer induced with 4T1 cells

Groups

Mean

Median

Estimate

Mean SD

95% confidence interval

Estimate

Mean SD

95% Confidence Interval

Lower limit

Upper limit

Lower limit

Upper limit

Anti LIF

70.66

16.33

38.65

102.68

63

13.06

37.39

88.6

Anti LIF & DOX

50.66

1.2

48.31

53.02

50

0.81

48.4

51.6

DOX

51.66

7.83

36.3

67.03

59

18.77

22.19

95.8

Control

60.33

7.53

45.56

75.1

56

4.89

46.39

65.6

  1. Anti LIF & DOX mice treated with anti-LIF and doxorubicin, DOX mice treated with doxorubicin, control: mice treated with phosphate buffer saline. The data were presented as mean ± SEM
Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us